New Insomnia Treatment Approved

January 16, 2020

New Insomnia Treatment Approved

Orexin receptor antagonist DAYVIGO TM has been approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults. The medication was tested in 2,000 patients before being approved by the FDA. Clinical trials are much more than just a drug, patient and a placebo, which is why Yourway offers ancillary material sourcing, including medical equipment and devices as well as diagnostic and testing equipment.

Back to Index

Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Schedule a Meeting

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Schedule a Meeting

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat

Hello! How can I help you?